Skip to content

PIEZOWAVE2 100505Recalls & reported problems

Richard Wolf GmbH · PIEZOWAVE 2 CONTROL UNIT for all standard indications in orthopedic extracorporeal shockwave therapy (ESWT) and trigger point shockwave therapy (TPST) and for the acoustic compression therapy (ACT), U: 100-127/220-240VAC, 50/60Hz, Dim. (wxhxd): 405x226x450mm · Class 1

Adverse event reports
3
Deaths reported
0
Injuries reported
3
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 04055207008454), received between Jan 30, 2025 and Nov 24, 2025 — classified as 3 injuries.

The most frequently reported specific device problem is “Insufficient Device Problem Information” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 1 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 1 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 1 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2
  • Insufficient Device Problem Information1

Patient problems

  • Insufficient Information1
  • No Clinical Signs, Symptoms or Conditions1
  • Stroke/CVA1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 24, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT A PIEZOWAVE 2 WAS USED ON A PATIENT FOR MYOFASCIAL ACOUSTIC COMPRESSION THERAPY (MYACT) ON THE LEFT LEG IN A MEDICAL FACILITY. THE PATIENT WAS SUBSEQUENTLY DIAGNOSED WITH AN ACUTE MENISCUS ROOT TEAR IN HER LEFT KNEE, CONFIRMED BY IMAGING, AS WELL AS PERSISTENT NEUROPATHIC SYMPTOMS; HOWEVER, BASED ON THE CURRENT CLINICAL ASSESSMENT AND AVAILABLE FINDINGS, A DIRECT CAUSAL LINK TO THE MYACT TREATMENT IS CONSIDERED UNLIKELY AND CANNOT BE CONFIRMED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 23633150 ↗
  • InjuryJul 8, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    RICHARD WOLF WAS INFORMED THAT A PATIENT EXPERIENCED A STROKE AFTER MANUAL CHIROPRACTIC MANIPULATION. PRIOR TO THE MANUAL CHIROPRACTIC TREATMENT, THE PIEZOWAVE WAS USED FOR MYOFASCIAL ACOUSTIC COMPRESSION MASSAGE. THERE IS NO INFORMATION AVAILABLE FROM THE CHIROPRACTOR ON THE SPECIFIC PIEZOWAVE CONTROL UNIT OR THERAPY SOURCE THAT WERE UTILIZED DURING THE TREATMENT. THE CHIROPRACTOR CONTINUES TO USE THE PIEZOWAVE UNITS AND THERAPY SOURCES FOR MYOFASCIAL ACOUSTIC COMPRESSION MASSAGE TREATMENT.

    Patient problems: Stroke/CVA

    MAUDE report 22442734 ↗
  • InjuryJan 30, 2025Insufficient Device Problem Information; Insufficient Device Problem Information

    RICHARD WOLF GMBH BECAME AWARE OF A PATIENT ALLEGATION OF POTENTIAL INJURY VIA A LAWSUIT FILED IN THE USA. NO FURTHER DETAILS WERE PROVIDED IN THE LAWSUIT.

    Patient problems: Insufficient Information

    MAUDE report 21277398 ↗

Other Massager, therapeutic, electric devices

All Massager, therapeutic, electric devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.